Skip To Main Content
This website is intended exclusively for healthcare professionals residing and/or working in Kuwait.
Campus
Campus

Diabetes
 

Tools and Resources

Discover our curated list of tools and resources to help you with your daily work

My Dose Coach Self Titration

My Dose Coach Self Titration

Learn More
My Dose Coach About MDC

My Dose Coach About MDC

Learn More
My Dose Coach Getting Started

My Dose Coach Getting Started

Learn More
My Dose Coach Patient Guide

My Dose Coach Patient Guide

Learn More
My Dose Coach Real World Evidence

My Dose Coach Real World Evidence

Learn More
Pre-Ramadan assessment and Risk calculation for people with diabetes who want to fast during Ramadan

Pre-Ramadan assessment and Risk calculation for people with diabetes who want to fast during Ramadan

Learn More
Clinical and economic value of Soliqua - Pharmacist perspective

Clinical and economic value of Soliqua - Pharmacist perspective

Learn More
My Dose Coach

My Dose Coach

Learn More

Support your patients during their Diabetes journey

Patients need to be inspired by high-quality medical information throughout their lives. 
You can then access content related to various stages of the journey as a patient.

Insulin and Other Medications Dose Adjustments for Type 1 and 2 Diabetes in Ramadan

Insulin and Other Medications Dose Adjustments for Type 1 and 2 Diabetes in Ramadan

Learn More
Insulin titration and technology-based solutions

Insulin titration and technology-based solutions

Learn More
Hypoglycemia

Hypoglycemia

Learn More
About Diabetes

About Diabetes

Learn More

Latest Trends

Explore a sample of scientific articles and videos that are popular with Medical Campus users.

Groundbreaking SoliD Study: Comparative Efficacy of iGlarLixi and IDegAsp

Groundbreaking SoliD Study: Comparative Efficacy of iGlarLixi and IDegAsp

Learn More
The ATOS Study: Real-World Study on Effectiveness of Insulin Glargine U300 in the Gulf Region.

The ATOS Study: Real-World Study on Effectiveness of Insulin Glargine U300 in the Gulf Region.

Learn More
An Evidence about The Role of Basal Insulin Glargine 300 U/mL Post-GLP-1 Therapy

An Evidence about The Role of Basal Insulin Glargine 300 U/mL Post-GLP-1 Therapy

Learn More
Advancing Therapy with iGlarLixi: Differentiation from other complex regimens
  • Diabetes

Advancing Therapy with iGlarLixi: Differentiation from other complex regimens

An educational video outlining key data from indirect comparisons of iGlarLixi versus IDegAsp.

Learn More
Advancing Therapy with iGlarLixi: Differentiation from complex insulin regimens
  • Diabetes

Advancing Therapy with iGlarLixi: Differentiation from complex insulin regimens

An educational video outlining key data from indirect comparisons of iGlarLixi versus IDegAsp.

Learn More
Challenges associated with commonly-used insulin advancement options
  • Diabetes

Challenges associated with commonly-used insulin advancement options

Learn More
Insulin advancement in Type 2 diabetes: Unmet needs with commonly-used options
  • Diabetes

Insulin advancement in Type 2 diabetes: Unmet needs with commonly-used options

Educational video on "Insulin advancement in Type 2 diabetes: Unmet needs with commonly-used options" outlining key data from indirect comparisons of iGlarLixi versus IDegAsp.

Learn More
Treatment simplification of complex insulin regimens in T2D
  • Diabetes

Treatment simplification of complex insulin regimens in T2D

An educational video to discuss the challenges associated with commonly-used insulin advancement options and the need for treatment simplification for many adults with T2D. The video reviews data supporting the use of BI + GLP-1 RA FRCs versus commonly-used insulin regimens in adults with T2D.

Learn More